Skip to main content
Log in

Pharmacokinetics of cimetidine in critically ill patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Cimetidine disposition was studied after rapid (1 min) intravenous infusion in eight critically ill patients aged between 20 years and 77 years; one patient was studied on two occasions. Cimetidine dose was 300 mg in seven patients and 400 mg in the remaining patient. Arterial plasma cimetidine concentrations at the end of the infusion were very high and ranged from approximately 15–35 mg/l. Pharmacokinetic parameters displayed wide interpatient variability (coefficients of variation of 30–50%) and significant relationships emerged between some of these parameters and certain patient characteristics. Most notable, total systemic plasma clearance of cimetidine was directly related to estimated creatinine clearance (p<0.01). This relationship might prove to be a useful method of individualizing cimetidine dosage in critically ill patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Halloran LG, Zfass AM, Gayle WE, Wheeler CB, Miller JD (1980) Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg 139: 44–48

    Google Scholar 

  2. McElwee HP, Sirinek KR, Levine BA (1979) Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury. Surgery 86: 620–626

    Google Scholar 

  3. Weigelt JA, Aurbakken CM, Gewertz BL, Snyder WH (1981) Cimetidine vs antacid in prophylaxis for stress ulceration. Arch Surg 116: 597–601

    Google Scholar 

  4. Somogyi A, Rohner H-G, Gugler R (1980) Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94

    Google Scholar 

  5. Larsson R, Erlanson P, Bodemar G, Walan A, Bertler A, Fransson L, Norlander B (1982) The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol 13: 163–170

    Google Scholar 

  6. Gugler R, Müller-Liebenau B, Somogyi A (1982) Altered disposition and availability of cimetidine in liver cirrhotic patients. Br J Clin Pharmacol 14: 421–429

    Google Scholar 

  7. Schentag JJ, Cerra FB, Calleri G, De Glopper E, Rose JQ, Bernhard H (1979) Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1: 177–181

    Google Scholar 

  8. MacMahon B, Bakshi M, Walsh MJ (1981) Cardiac arrhythmias after intravenous cimetidine. N Engl J Med 305: 832–833

    Google Scholar 

  9. Cohen IA, Siepler JK, Nation R, Bombeck CT, Nyhus LM (1980) Relationship between cimetidine plasma levels and gastric acidity in acutely ill patients. Am J Hosp Pharm 37: 375–379

    Google Scholar 

  10. Metzler CM (1969) Nonlin, a computer program for parameter estimations in nonlinear situations. Upjohn Co, Kalamazoo, Michigan

    Google Scholar 

  11. Loo JCK, Riegelman S (1970) Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i.v. infusion. J Pharm Sci 59: 53–55

    Google Scholar 

  12. Wagner JG (1976) Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of the polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 4: 443–467

    Google Scholar 

  13. Lam G, Chiou WL (1981) Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs. Res Commun Chem Pathol Pharmacol 33: 33–48

    Google Scholar 

  14. Burland WL, Duncan WAM, Hesselbo T, Mills JG, Sharpe PC, Haggie SJ, Wylie JH (1975) Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man. Br J Clin Pharmacol 2: 481–486

    Google Scholar 

  15. Gugler R, Fuchs G, Dieckmann M, Somogyi A (1981) Cimetidine plasma concentration-response relationships. Clin Pharmacol Ther 29: 744–748

    Google Scholar 

  16. Cohen J, Weetman AP, Dargie HJ, Krikler DM (1979) Life-threatening arrhythmias and intravenous cimetidine. Br Med J 2: 768

    Google Scholar 

  17. Lee PK, Lai CL, Lok ASF, Tse TF, Lai KN, Chow SF, Lam KC (1981) Haemodynamic responses to intravenous cimetidine in subjects with normal lung function and in subjects with chronic airway obstruction. Br J Clin Pharmacol 11: 339–343

    Google Scholar 

  18. Mahon WA, Kotton M (1978) Hypotension after intravenous cimetidine. Lancet 1: 828

    Google Scholar 

  19. Triggs EJ, Nation RL (1975) Pharmacokinetics in the aged: a review. J Pharmacokinet Biopharm 3: 387–418

    Google Scholar 

  20. Crooks J, O'Malley K, Stevenson IH (1976) Pharmacokinetics in the elderly. Clin Pharmacokinet 1: 280–296

    Google Scholar 

  21. Redolfi A, Borgogelli E, Lodola E (1979) Blood level of cimetidine in relation to age. Europ J Clin Pharmacol 15: 257–261

    Google Scholar 

  22. Siersbaek-Nielsen K, Hansen JM, Kampmann J, Kristensen M (1971) Rapid evaluation of creatinine clearance. Lancet 1: 1133–1134

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nation, R.L., Ilett, K.F., Tjokrosetio, R. et al. Pharmacokinetics of cimetidine in critically ill patients. Eur J Clin Pharmacol 26, 341–346 (1984). https://doi.org/10.1007/BF00548765

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548765

Key words

Navigation